|
WO1998008517A2
(en)
*
|
1996-08-26 |
1998-03-05 |
Takeda Chemical Industries, Ltd. |
Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol
|
|
US3565924A
(en)
|
1968-07-01 |
1971-02-23 |
Wisconsin Alumni Res Found |
25-hydroxycholfcalciferol
|
|
US3833622A
(en)
|
1969-03-17 |
1974-09-03 |
Upjohn Co |
Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds
|
|
US3974272A
(en)
*
|
1972-09-01 |
1976-08-10 |
Merck & Co., Inc. |
Palatable cholestyramine coacervate compositions
|
|
US3880894A
(en)
|
1974-05-24 |
1975-04-29 |
Wisconsin Alumni Res Found |
1,25-Dihydroxyergocalciferol
|
|
US4004003A
(en)
|
1974-08-28 |
1977-01-18 |
The Upjohn Company |
25-Hydroxycalciferol compounds for treatment of steroid-induced osteoporosis
|
|
US4230701A
(en)
|
1979-03-21 |
1980-10-28 |
Hoffmann-La Roche Inc. |
Administration of biologically active vitamin D3 and vitamin D2 materials
|
|
US4335120A
(en)
|
1979-03-21 |
1982-06-15 |
Hoffmann-La Roche Inc. |
Administration of biologically active vitamin D3 and vitamin D2 materials
|
|
JPS5832823A
(ja)
|
1981-08-20 |
1983-02-25 |
Chugai Pharmaceut Co Ltd |
脱癌剤
|
|
US4721613A
(en)
|
1982-12-13 |
1988-01-26 |
Alza Corporation |
Delivery system comprising means for shielding a multiplicity of reservoirs in selected environment of use
|
|
JPS59155309A
(ja)
|
1983-02-22 |
1984-09-04 |
Teijin Ltd |
活性型ビタミンｄ↓３類組成物
|
|
US4684524A
(en)
|
1984-03-19 |
1987-08-04 |
Alza Corporation |
Rate controlled dispenser for administering beneficial agent
|
|
US4555364A
(en)
|
1984-11-01 |
1985-11-26 |
Wisconsin Alumni Research Foundation |
Method for preparing 1-hydroxyvitamin D compounds
|
|
US4695591A
(en)
|
1985-03-29 |
1987-09-22 |
Schering Corporation |
Controlled release dosage forms comprising hydroxypropylmethylcellulose
|
|
US4668517A
(en)
|
1985-04-04 |
1987-05-26 |
Norwich Eaton Pharmaceuticals, Inc. |
Furazolidone dosage form
|
|
DE3676235D1
(de)
|
1985-06-04 |
1991-01-31 |
Teijin Ltd |
Arzneizubereitung mit verzoegerter wirkstoffabgabe.
|
|
JPS61293911A
(ja)
|
1985-06-24 |
1986-12-24 |
Teisan Seiyaku Kk |
徐放化製剤
|
|
US5167965A
(en)
*
|
1987-02-09 |
1992-12-01 |
The Dow Chemical Company |
Palatable cholestyramine granules, tablets and methods for preparation thereof
|
|
US4997824A
(en)
|
1987-07-22 |
1991-03-05 |
Teva Pharmaceutical Industries Ltd. |
Combination of cholecalciferol derivatives for the treatment of renal bone disease
|
|
US5104864A
(en)
|
1988-08-02 |
1992-04-14 |
Bone Care International, Inc. |
Method for treating and preventing loss of bone mass
|
|
US5869473A
(en)
|
1988-08-02 |
1999-02-09 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
|
US5602116A
(en)
|
1988-08-02 |
1997-02-11 |
Bone Care International, Inc. |
Method for treating and preventing secondary hyperparathyroidism
|
|
JP2893191B2
(ja)
|
1988-11-08 |
1999-05-17 |
武田薬品工業株式会社 |
放出制御性マトリックス剤
|
|
JPH02240024A
(ja)
|
1989-03-13 |
1990-09-25 |
Ss Pharmaceut Co Ltd |
活性型ビタミンｄ↓３類製剤用組成物
|
|
US5026559A
(en)
|
1989-04-03 |
1991-06-25 |
Kinaform Technology, Inc. |
Sustained-release pharmaceutical preparation
|
|
GB9004544D0
(en)
|
1990-03-01 |
1990-04-25 |
Leo Pharm Prod Ltd |
Novel treatment ii
|
|
JP2845342B2
(ja)
|
1990-04-28 |
1999-01-13 |
大正製薬株式会社 |
ビタミンｄ▲下３▼誘導体含有固形製剤組成物
|
|
JP2893140B2
(ja)
|
1990-11-30 |
1999-05-17 |
エスエス製薬株式会社 |
安定なビタミンｄ製剤
|
|
JPH04288016A
(ja)
|
1991-03-14 |
1992-10-13 |
Tokai Capsule Kk |
活性型ビタミンｄ３類軟カプセル剤の製造方法
|
|
TW212761B
(pl)
|
1991-04-09 |
1993-09-11 |
Takeda Pharm Industry Co Ltd |
|
|
US5693615A
(en)
|
1991-06-05 |
1997-12-02 |
The Procter & Gamble Company |
Therapeutic compositions for osteoinduction
|
|
US5266331A
(en)
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
|
US5472712A
(en)
|
1991-12-24 |
1995-12-05 |
Euroceltique, S.A. |
Controlled-release formulations coated with aqueous dispersions of ethylcellulose
|
|
US5160742A
(en)
|
1991-12-31 |
1992-11-03 |
Abbott Laboratories |
System for delivering an active substance for sustained release
|
|
DK0600079T3
(da)
|
1992-06-22 |
2002-04-15 |
Bone Care Int Inc |
Oral 1alpha-hydroxyprævitamin D
|
|
US5795882A
(en)
|
1992-06-22 |
1998-08-18 |
Bone Care International, Inc. |
Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
|
|
US5354743A
(en)
|
1992-09-15 |
1994-10-11 |
Thys Jacobs Susan |
Method for the treatment of premenstrual syndrome with vitamin D
|
|
US5431917A
(en)
|
1992-10-08 |
1995-07-11 |
Japan Elanco Company, Ltd. |
Hard capsule for pharmaceutical drugs and method for producing the same
|
|
US5342626A
(en)
|
1993-04-27 |
1994-08-30 |
Merck & Co., Inc. |
Composition and process for gelatin-free soft capsules
|
|
JP2684587B2
(ja)
|
1993-06-21 |
1997-12-03 |
呉羽化学工業株式会社 |
腎性骨異栄養症における骨量減少抑制剤
|
|
US6121469A
(en)
|
1993-12-23 |
2000-09-19 |
The Regents Of The University Of California |
Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs
|
|
JPH07242550A
(ja)
*
|
1994-03-02 |
1995-09-19 |
Teijin Ltd |
二次性副甲状腺機能亢進症治療剤
|
|
IL110117A0
(en)
|
1994-06-24 |
1994-10-07 |
Univ Ben Gurion |
Pharmaceutical compositions comprising vitamin-d analogs
|
|
SE9402422D0
(sv)
|
1994-07-08 |
1994-07-08 |
Astra Ab |
New beads for controlled release and a pharmaceutical preparation containing the same
|
|
EP0769936A1
(en)
|
1994-07-22 |
1997-05-02 |
G.D. Searle & Co. |
Self-emulsifying drug delivery system
|
|
JPH0892098A
(ja)
|
1994-09-27 |
1996-04-09 |
Teijin Ltd |
肺結核治療剤
|
|
US5756123A
(en)
|
1994-12-01 |
1998-05-26 |
Japan Elanco Co., Ltd. |
Capsule shell
|
|
US6242434B1
(en)
|
1997-08-08 |
2001-06-05 |
Bone Care International, Inc. |
24-hydroxyvitamin D, analogs and uses thereof
|
|
US20040043971A1
(en)
*
|
1995-04-03 |
2004-03-04 |
Bone Care International, Inc. |
Method of treating and preventing hyperparathyroidism with active vitamin D analogs
|
|
US20020183288A1
(en)
*
|
1995-04-03 |
2002-12-05 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
|
US6376479B1
(en)
|
1995-04-03 |
2002-04-23 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
|
JP3372259B2
(ja)
|
1995-09-21 |
2003-01-27 |
ウィスコンシン・アルムニ・リサーチ・ファウンデーション |
カルシトリオール誘導体およびそれらの用途
|
|
DE19549243A1
(de)
|
1995-12-21 |
1997-06-26 |
Schering Ag |
Pharmazeutische Präparate enthaltend Clathrate von Cyclodextrinen und nichtnatürliche Vitamin D-Analoga
|
|
US5958451A
(en)
|
1996-09-03 |
1999-09-28 |
Yung Shin Pharm Ind. Co., Ltd. |
Process for producing porous, controlled-release capsules and encapsulated composition
|
|
JP2002511777A
(ja)
|
1996-10-28 |
2002-04-16 |
ゼネラル ミルズ，インコーポレイテッド |
調放性粒子の埋包およびカプセル化
|
|
JPH10158171A
(ja)
|
1996-12-02 |
1998-06-16 |
Kita:Kk |
ビタミンｄ化合物を配合した眼内投与剤
|
|
US6503893B2
(en)
*
|
1996-12-30 |
2003-01-07 |
Bone Care International, Inc. |
Method of treating hyperproliferative diseases using active vitamin D analogues
|
|
US20020128240A1
(en)
|
1996-12-30 |
2002-09-12 |
Bone Care International, Inc. |
Treatment of hyperproliferative diseases using active vitamin D analogues
|
|
US20030129194A1
(en)
|
1997-02-13 |
2003-07-10 |
Bone Care International, Inc. |
Targeted therapeutic delivery of vitamin D compounds
|
|
US6034075A
(en)
|
1997-03-20 |
2000-03-07 |
The Trustees Of Columbia University In The City Of New York |
Method of treating polycystic ovarian syndrome
|
|
JPH1175863A
(ja)
|
1997-07-10 |
1999-03-23 |
Kyowa Hakko Kogyo Co Ltd |
２５−ヒドロキシビタミンＤ３−１α−水酸化酵素および該酵素をコードするＤＮＡ
|
|
WO1999011272A1
(en)
|
1997-09-02 |
1999-03-11 |
Johns Hopkins University School Of Medicine |
Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders
|
|
WO1999049870A1
(en)
|
1998-03-27 |
1999-10-07 |
Oregon Health Sciences University |
Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
|
|
US6197340B1
(en)
|
1998-05-28 |
2001-03-06 |
Medical Research Institute |
Controlled release lipoic acid
|
|
SK287111B6
(sk)
|
1998-08-27 |
2009-12-07 |
Pharmacia & Upjohn Ab |
Farmaceutický prípravok obsahujúci tolterodin s regulovaným uvoľňovaním
|
|
SE9803871D0
(sv)
|
1998-11-11 |
1998-11-11 |
Pharmacia & Upjohn Ab |
Therapeutic method and formulation
|
|
US6139875A
(en)
|
1998-09-29 |
2000-10-31 |
Eastman Chemical Company |
Aqueous enteric coating composition and low gastric permeability enteric coating
|
|
WO2000018374A1
(en)
|
1998-10-01 |
2000-04-06 |
Elan Pharma International, Ltd. |
Controlled release nanoparticulate compositions
|
|
DE69940821D1
(de)
|
1998-10-09 |
2009-06-10 |
Gen Mills Inc |
Verkapselung empfindlicher flüssiger komponenten in eine matrix zur gewinnung diskreter lagerbeständiger partikel
|
|
JP3449253B2
(ja)
|
1998-10-29 |
2003-09-22 |
シオノギクオリカプス株式会社 |
硬質カプセルの製造方法
|
|
JP2000206312A
(ja)
*
|
1998-11-12 |
2000-07-28 |
Olympus Optical Co Ltd |
光学素子
|
|
WO2000035419A2
(en)
|
1998-12-17 |
2000-06-22 |
Alza Corporation |
Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
|
|
US6342249B1
(en)
|
1998-12-23 |
2002-01-29 |
Alza Corporation |
Controlled release liquid active agent formulation dosage forms
|
|
US6432936B1
(en)
|
1999-01-20 |
2002-08-13 |
Wisconsin Alumni Research Foundation |
Crystalline 1α-hydroxyvitamin D2 and method of purification thereof
|
|
US6248363B1
(en)
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
ATE344039T1
(de)
|
1999-04-01 |
2006-11-15 |
Univ Johns Hopkins |
Nicht-calcemische, transkriptionell-aktive, schwefelhaltige analoga von 1-alpha, 25- dihydroxyvitamin d3 mit antiproliferativer wirkung
|
|
DE19916419B4
(de)
|
1999-04-08 |
2005-06-16 |
Schering Ag |
Kombinationspräparat aus Vitamin-D-Metaboliten oder Vitamin-D-Analoga und einem Östrogenpartialagonisten zur Behandlung von Osteoporose
|
|
AU5139600A
(en)
*
|
1999-05-27 |
2000-12-18 |
Drugtech Corporation |
Nutritional formulations
|
|
US6340473B1
(en)
|
1999-07-07 |
2002-01-22 |
R.P. Scherer Technologies, Inc. |
Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
|
|
US6274169B1
(en)
|
1999-08-02 |
2001-08-14 |
Abbott Laboratories |
Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol
|
|
US6051567A
(en)
|
1999-08-02 |
2000-04-18 |
Abbott Laboratories |
Low oxygen content compositions of 1α, 25-dihydroxycholecalciferol
|
|
AU6866900A
(en)
|
1999-08-31 |
2001-03-26 |
Chugai Seiyaku Kabushiki Kaisha |
Soft capsules
|
|
US20060034937A1
(en)
|
1999-11-23 |
2006-02-16 |
Mahesh Patel |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
GB0007419D0
(en)
|
2000-03-27 |
2000-05-17 |
Smithkline Beecham Gmbh |
Composition
|
|
US6375981B1
(en)
|
2000-06-01 |
2002-04-23 |
A. E. Staley Manufacturing Co. |
Modified starch as a replacement for gelatin in soft gel films and capsules
|
|
EP1301479A2
(en)
|
2000-07-18 |
2003-04-16 |
Bone Care International, Inc. |
STABILIZED 1$g(a)-HYDROXY VITAMIN D
|
|
AU8013801A
(en)
|
2000-08-29 |
2002-03-13 |
Nisshin Kasei Co Ltd |
Hard capsule
|
|
MXPA03003895A
(es)
|
2000-10-30 |
2003-07-28 |
Euro Celtique Sa |
Formulaciones de hidrocodona de liberacion controlada.
|
|
US6479649B1
(en)
|
2000-12-13 |
2002-11-12 |
Fmc Corporation |
Production of carrageenan and carrageenan products
|
|
RU2262922C2
(ru)
*
|
2001-05-15 |
2005-10-27 |
Уорнер-Ламберт Компани Ллс |
Способ прессования для получения лекарственной формы фенитоина натрия
|
|
CA2452577C
(en)
|
2001-07-05 |
2011-04-19 |
Wakunaga Pharmaceutical Co., Ltd. |
Soft capsules
|
|
US7033996B2
(en)
|
2001-08-31 |
2006-04-25 |
University Of Medicine & Dentistry Of New Jersey |
Method for the treatment of vitamin D related disease
|
|
DE10149674A1
(de)
*
|
2001-10-09 |
2003-04-24 |
Apogepha Arzneimittel Gmbh |
Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
|
|
JP4436674B2
(ja)
|
2001-10-12 |
2010-03-24 |
ジョンズ ホプキンス ユニバーシティ |
１α，２５−ジヒドロキシビタミンＤ３の低カルシウム血症性オキシム類似体
|
|
US6524788B1
(en)
|
2001-11-02 |
2003-02-25 |
Thomas L. Cantor |
Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
|
|
US7056655B2
(en)
|
2001-11-02 |
2006-06-06 |
Scantibodies Laboratory, Inc. |
Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism
|
|
ITMI20012366A1
(it)
|
2001-11-09 |
2003-05-09 |
Farmatron Ltd |
Sistemi terapeutici stabilizzati a rilascio immediato e/o modificato per la somministrazione orale di principi attivi e/o eccipienti e/o ali
|
|
KR20100047349A
(ko)
|
2001-11-22 |
2010-05-07 |
모리시타 진탄 가부시키가이샤 |
비젤라틴계 캡슐 피막 조성물 및 이를 이용한 캡슐
|
|
BR0214679A
(pt)
|
2001-12-03 |
2004-12-14 |
Novacea Inc |
Composições farmacêuticas compreendendo compostos a base de vitamina d ativa
|
|
FR2829142B1
(fr)
|
2001-12-27 |
2004-02-13 |
Ulice |
Composition filmogene d'heteroxylanes pour la fabrication de capsules ainsi obtenues
|
|
US7632518B2
(en)
|
2002-01-15 |
2009-12-15 |
Dsm Ip Assets B.V. |
25-hydroxy vitamin D3 compositions
|
|
US6949256B2
(en)
|
2002-01-18 |
2005-09-27 |
Banner Pharmacaps, Inc. |
Non-gelatin capsule shell formulation
|
|
NO20021592D0
(no)
|
2002-04-04 |
2002-04-04 |
Fmc Biopolymer As |
Polysakkaridkapsler og fremgangsmåte ved fremstilling derav
|
|
AU2003226148A1
(en)
*
|
2002-04-05 |
2003-10-27 |
Merck & Co., Inc. |
Method for inhibiting bone resorption with an alendronate and vitamin d formulation
|
|
ATE543796T1
(de)
|
2002-06-13 |
2012-02-15 |
Univ Johns Hopkins |
24-sulfoximine vitamin d3 derivate
|
|
DE60334378D1
(de)
|
2002-07-05 |
2010-11-11 |
Temrel Ltd |
Zusammensetzung zur kontrollierten wirkstoffabgabe
|
|
KR100699516B1
(ko)
*
|
2002-07-29 |
2007-03-26 |
알자 코포레이션 |
팔리페리돈의 조절 전달을 위한 방법 및 복용 형태
|
|
US8268352B2
(en)
|
2002-08-05 |
2012-09-18 |
Torrent Pharmaceuticals Limited |
Modified release composition for highly soluble drugs
|
|
AU2002368245A1
(en)
|
2002-09-26 |
2004-04-19 |
Young-Kweon Choi |
Matrix type patch for transdermal administration of vitamin d analog and the use thereof
|
|
US20050101576A1
(en)
|
2003-11-06 |
2005-05-12 |
Novacea, Inc. |
Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
|
|
US8999372B2
(en)
|
2002-11-14 |
2015-04-07 |
Cure Pharmaceutical Corporation |
Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
|
|
JP2004175750A
(ja)
|
2002-11-28 |
2004-06-24 |
Kose Corp |
皮膚障害抑制剤、皮膚障害改善剤、及びそれらを含有する皮膚外用剤
|
|
WO2004058235A2
(en)
|
2002-12-16 |
2004-07-15 |
Teva Pharmaceutical Industries Ltd. |
Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin d derivative
|
|
EP1592410B1
(en)
*
|
2003-02-11 |
2008-07-23 |
Alza Corporation |
Methods and dosage forms with modified layer geometry
|
|
US7816341B2
(en)
|
2003-04-14 |
2010-10-19 |
Fmc Corporation |
Homogeneous, thermoreversible gel containing reduced viscosity carrageenan and products made therefrom
|
|
EP1628643B9
(en)
|
2003-04-14 |
2013-06-12 |
Fmc Corporation |
Homogeneous, thermoreversible gel film containing kappa-2 carrageenan and soft capsules made therefrom
|
|
EP1622455A4
(en)
*
|
2003-04-30 |
2009-12-16 |
Bioxell Spa |
GEMINI VITAMIN D3 COMPOUNDS AND METHOD FOR THEIR USE
|
|
EP1479677A1
(en)
|
2003-05-19 |
2004-11-24 |
Aventis Pharma Deutschland GmbH |
New indole derivatives as factor xa inhibitors
|
|
CA2529495C
(en)
|
2003-06-16 |
2013-02-05 |
Solx, Inc. |
Shunt for the treatment of glaucoma
|
|
US20050124591A1
(en)
|
2003-07-29 |
2005-06-09 |
Jin Tian |
Use of vitamin Ds to treat kidney disease
|
|
US20050148557A1
(en)
|
2003-07-29 |
2005-07-07 |
Jin Tian |
Use of Vitamin Ds to treat kidney disease
|
|
CA2539708A1
(en)
*
|
2003-09-24 |
2005-04-07 |
Bioxell S.P.A. |
1,3-diaclyated,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
|
|
EP1694333A2
(en)
|
2003-11-25 |
2006-08-30 |
Deltanoid Pharmaceuticals, Inc. |
Methods for reducing body fat using vitamin d compounds
|
|
US20060009425A1
(en)
|
2004-05-28 |
2006-01-12 |
Leticia Delgado-Herrera |
Oral formulations of paricalcitol
|
|
JP2008502605A
(ja)
|
2004-06-16 |
2008-01-31 |
スマート ドラッグ システムズ インコーポレイティド |
徐放性ワクチン組成物
|
|
WO2006007323A2
(en)
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents
|
|
US20060019933A1
(en)
|
2004-07-22 |
2006-01-26 |
David Boardman |
Process for preparing stabilized vitamin D
|
|
KR20070043806A
(ko)
|
2004-07-29 |
2007-04-25 |
사노피-아벤티스 |
ｐＨ에 매우 의존적인 용해도를 가지는 활성 성분의 제어방출을 위한 약제학적 다층 정제
|
|
JP2008516971A
(ja)
*
|
2004-10-15 |
2008-05-22 |
アルテアーナノ，インコーポレーテッド |
錠剤による負荷が軽減されるリン酸塩結合剤
|
|
US8231896B2
(en)
|
2004-11-08 |
2012-07-31 |
R.P. Scherer Technologies, Llc |
Non-gelatin soft capsule system
|
|
AU2004325362B2
(en)
|
2004-12-03 |
2012-09-06 |
Council Of Scientific And Industrial Research |
Process of preparation of biodegradable films from semi refined kappa carrageenan
|
|
US8318210B2
(en)
|
2005-02-28 |
2012-11-27 |
Neos Therapeutics, Lp |
Compositions and methods of making sustained release liquid formulations
|
|
US7745226B2
(en)
|
2005-04-06 |
2010-06-29 |
Quest Diagnostics Investments Incorporated |
Methods for detecting vitamin D metabolites
|
|
CA2604943C
(en)
|
2005-04-15 |
2013-09-17 |
Clarus Therapeutics, Inc. |
Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
|
|
US20060257481A1
(en)
|
2005-04-21 |
2006-11-16 |
Decode Genetics Ehf. |
Sustained release formulation and dosing schedule of leukotriene synthesis inhibitor for human therapy
|
|
US20080134937A1
(en)
|
2005-05-25 |
2008-06-12 |
Joo Hwan Yang |
Cellulose hard capsule enhancing mechanical film strength
|
|
AR055099A1
(es)
|
2005-07-28 |
2007-08-08 |
Alza Corp |
Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
|
|
JP2009509992A
(ja)
|
2005-09-29 |
2009-03-12 |
エフ．ホフマン−ラ ロシュ アーゲー |
２５−ヒドロキシビタミンｄに対する抗体
|
|
ITFI20050206A1
(it)
|
2005-09-30 |
2007-04-01 |
Valpharma Sa |
Composizione farmaceutica a rilascio controllato di venlafaxina cloridrato, e processo per la sua preparazione
|
|
WO2007047327A2
(en)
*
|
2005-10-12 |
2007-04-26 |
Proventiv Therapeutics, Llc |
Methods and articles for treating 25-hydroxyvitamin d insufficiency and deficiency
|
|
CA2627292C
(en)
|
2005-10-26 |
2012-04-17 |
Banner Pharmacaps, Inc. |
Hydrophilic vehicle-based dual controlled release matrix system
|
|
US8293270B2
(en)
|
2005-10-26 |
2012-10-23 |
Banner Pharmacaps, Inc. |
Lipophilic vehicle-based dual controlled release matrix system
|
|
KR101372110B1
(ko)
|
2005-11-01 |
2014-03-14 |
씨피 켈코 유에스, 인코포레이티드 |
고점도 디우탄 검 및 제조 방법
|
|
WO2007068287A1
(en)
|
2005-12-15 |
2007-06-21 |
Laboratoria Qualiphar |
Sustained release vitamin preparation
|
|
SI3095447T1
(sl)
*
|
2006-02-03 |
2022-02-28 |
Opko Renal, Llc |
Zdravljenje pomanjkanja vitamina D s 25-hidroksivitaminom D2 in 25-hidroksivitaminom D3
|
|
EP2024436A1
(en)
|
2006-06-06 |
2009-02-18 |
Fmc Corporation |
Kappa-2 carrageenan composition and products made therefrom
|
|
HUE037309T2
(hu)
*
|
2006-06-21 |
2018-08-28 |
Opko Ireland Global Holdings Ltd |
Terápia D-vitamin telítési szer alkalmazásával és D-vitamin hormon helyettesítõ szer
|
|
KR20120038021A
(ko)
|
2006-10-27 |
2012-04-20 |
화이자 프로덕츠 인코포레이티드 |
하이드록시프로필 메틸 셀룰로스 경질 캡슐 및 이의 제조 방법
|
|
WO2008097646A1
(en)
|
2007-02-09 |
2008-08-14 |
Schering Corporation |
Methods to treat and/or prevent mucositis
|
|
PT3335712T
(pt)
|
2007-04-25 |
2025-10-23 |
Opko Renal Llc |
Método de tratamento e prevenção seguro e eficaz do hiperparatiroidismo secundário na doença renal crónica
|
|
PL2148661T3
(pl)
|
2007-04-25 |
2013-07-31 |
Cytochroma Inc |
Doustne kompozycje o kontrolowanym uwalnianiu zawierające związek będący witaminą D i woskowy nośnik
|
|
DK2148684T3
(da)
|
2007-04-25 |
2013-04-22 |
Cytochroma Inc |
Fremgangsmåde til behandling af vitamin D-insufficiens og -deficiens
|
|
DE102008006203B4
(de)
*
|
2008-01-26 |
2011-03-17 |
Jost-Werke Gmbh |
Fahrzeugkupplung zum Herstellen einer mechanischen Verbindung zwischen einem ersten und einem zweiten Fahrzeug
|
|
ES2599761T5
(en)
|
2008-02-13 |
2025-06-18 |
Dsm Ip Assets Bv |
Use of 25-hydroxy-vitamin d3 and vitamin d to affect human muscle physiology
|
|
CN106214683A
(zh)
|
2008-02-13 |
2016-12-14 |
帝斯曼知识产权资产管理有限公司 |
维生素d和25‑羟基维生素d3的组合
|
|
WO2010011906A1
(en)
|
2008-07-24 |
2010-01-28 |
Wisconsin Alumni Research Foundation |
Once-a-week administration of 25-hydroxy vitamin d3 to sustain elevated steady-state pharmacokinetic blood concentration
|
|
MX2011003047A
(es)
|
2008-09-24 |
2011-04-14 |
Evonik Roehm Gmbh |
Composicion farmaceutica de opioide de liberacion controlada ph dependiente con resistencia contra la influencia de etanol.
|
|
KR101760534B1
(ko)
|
2009-09-10 |
2017-07-21 |
에프엠씨 코포레이션 |
이음매 없는 알기네이트 캡슐
|
|
US8101203B2
(en)
|
2010-01-14 |
2012-01-24 |
Karl Wei Cao |
Hard capsule composition and method of use
|
|
US8101204B2
(en)
|
2010-01-14 |
2012-01-24 |
Karl Wei Cao |
Hard capsule composition and method of use
|
|
WO2011095388A1
(en)
|
2010-02-04 |
2011-08-11 |
Synthon Bv |
Tolterodine bead
|
|
BR112013002721B8
(pt)
|
2010-08-04 |
2021-05-25 |
Scherer Technologies Llc R P |
composição formadora de filme para cápsulas moles, cápsulas moles e seu invólucro
|
|
CN106924268A
(zh)
|
2010-12-06 |
2017-07-07 |
帝斯曼知识产权资产管理有限公司 |
用25‑羟基‑维生素d3治疗与嗜酸性粒细胞趋化因子增高有关的病症
|
|
EP2635611B1
(en)
|
2010-12-28 |
2017-01-11 |
Future Diagnostics B.V. |
Release reagent for vitamin d
|
|
WO2012117236A1
(en)
|
2011-03-02 |
2012-09-07 |
D3 Pharma Limited |
Vitamin d composition
|
|
ES2617654T3
(es)
|
2011-04-20 |
2017-06-19 |
Suheung Co., Ltd. |
Composición de la cubierta de cápsula blanda de origen no animal que tiene dureza de la cubierta y desintegración, mejoradas
|
|
CN102771688A
(zh)
|
2011-05-13 |
2012-11-14 |
富曼实（上海）商贸有限公司 |
可食用液体填充的多糖胶囊
|
|
EP2815745A1
(en)
|
2013-06-21 |
2014-12-24 |
Swiss Caps Rechte und Lizenzen AG |
Soft shell capsule and process for its manufacture
|
|
CN103495176B
(zh)
|
2013-10-26 |
2015-01-28 |
中山市凯博思淀粉材料科技有限公司 |
一种共混挤出法制备淀粉基软胶囊的方法
|
|
CN103520133B
(zh)
|
2013-10-26 |
2015-02-04 |
中山市凯博思淀粉材料科技有限公司 |
一种淀粉基软胶囊的制备方法
|